Through the use of a well-established mouse model of Pten loss-of-function-induced endometrioid endometrial carcinoma, this study demonstrates that the loss of Pgrmc2 attenuates endometrial hyperplasia and cancer incidence and severity, in part, by inhibiting endometrial glandular epithelial cell proliferation. The gene discussed is PTEN; the disease is cancer.